2014
The Canadian Cancer Clinical Trials Network (3CTN) launches to increase enrollment in investigator-initiated trials.
Canadian Strategy for Cancer Control (2019-2029)
The refreshed Canadian Strategy for Cancer Control is here. Based on input from more than 7,500 Canadians including healthcare leaders from across the country, the Strategy sets the course for a more equitable approach to cancer in Canada. No matter who we are or where we live, we should all have access to world-class ... Read More »
The refreshed Canadian Strategy for Cancer Control is here. Based on input from more than 7,500 Canadians including healthcare leaders from across the country, the Strategy sets the course for a more equitable approach to cancer in Canada. No matter who we are or where we live, we should all have access to world-class ... Read More »
The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »